Answers are grounded in this paper and cite their sources.
Purpose: To describe the preliminary outcomes following implementation of an institutional protocol for preoperative botulinum toxin A (BTA) injection in children with large abdominal wall defects. Methods: An institutional protocol was developed based on a systematic review of the literature and the authors’ clinical experience. A descriptive observational case series was conducted to evaluate its initial outcomes. Demographic data, defect characteristics, BTA administration technique, surgical approach, and complications were recorded. The anatomical effect of BTA was assessed through ultrasonographic measurements of abdominal muscle thickness before and after injection. Muscle thickness and its potential association with administered dose were analyzed. Results: Six patients were included, ranging in age from 10 months to 15 years. BTA was administered bilaterally under ultrasound guidance into the three lateral abdominal wall muscles, 24–35 days prior to surgery. The dose ranged from 3 to 15.4 U/kg. A mean reduction in muscle thickness of 4.8 mm (range 2.5–9 mm) was observed, which was statistically significant (p = 0.035). No dose–response relationship was identified. No severe BTA-related complications were recorded. Fascial closure was achieved in all cases, without the need for component separation (CS) in three patients. One recurrence with a minimal fascial defect was documented (mean follow-up 15.2 months). Conclusion: Implementation of an institutional protocol for the use of BTA in pediatric abdominal wall reconstruction demonstrated favorable short-term preliminary outcomes. Comparative studies with larger sample sizes and longer follow-up are warranted.
No takes yet. Share an insight, caveat, or question.
Gómez et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: